Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
To date, no clinical trial has specifically evaluated BPC-157s potential to promote tumors or metastasis
People might prefer to get BPC-157 on the gray market, rather than risk being assigned to the placebo group
Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
The medication should be transported in an insulated cooler with ice packs if refrigeration will not be available during travel, taking care to prevent direct contact with ice to avoid freezing
US$ 28.37
US$ 24.49
US$ 22.76
US$ 21.23
US$ 26.39
US$ 22.81
